IL-1-driven stromal–neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapiesMatthias Friedrich, Dharshan Sathananthan, Kara G. Lassen et al.|Nature Medicine|2021Cited by 289
A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel diseaseTom Thomas, Christopher D. Buckley, Charlotte Rich‐Griffin et al.|Nature Immunology|2024Cited by 83
MHC class II antigen presentation by intestinal epithelial cells fine-tunes bacteria-reactive CD4 T-cell responsesCornelia Heuberger, Kevin J. Maloy, Emily Thornton et al.|Mucosal Immunology|2023Cited by 44
MHC class II antigen presentation by intestinal epithelial cells fine-tunes bacteria-reactive CD4 T cell responsesCornelia Heuberger, Kevin J. Maloy, Emily Thornton et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 3
WITHDRAWN: Anti-TNF-induced IL-27 modulates regulatory T cell responses in patients with IBD that respond to therapyRaphael Sanches Peres, Fiona Powrie, Charlotte Rich‐Griffin et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 2